Evotec (EVO) News Today $5.44 +0.34 (+6.67%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Evotec (NASDAQ:EVO) Sees Large Volume Increase - Here's What HappenedEvotec (NASDAQ:EVO) Sees Strong Trading Volume - Still a Buy?November 15 at 12:50 PM | marketbeat.comEvotec jumps as Halozyme confirms takeover interest (updated)November 14 at 9:38 PM | seekingalpha.comHalozyme Therapeutics Bids to Acquire German Competitor EvotecNovember 14 at 9:38 PM | marketwatch.comHalozyme Therapeutics Proposes To Acquire Evotec For EUR 11.00/shr In CashNovember 14 at 9:38 PM | markets.businessinsider.comHalozyme interested in acquiring Evotec for $2.1B, Bloomberg saysNovember 14 at 9:38 PM | markets.businessinsider.comEvotec jumps on report Halozyme expressed takeover interestNovember 14 at 9:38 PM | msn.comGermany’s Evotec Gets Takeover Interest From HalozymeNovember 14 at 4:35 PM | bloomberg.comHalozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash TransactionNovember 14 at 4:15 PM | prnewswire.comHalozyme weighing buyout of drugmaker Evotec, Bloomberg News reportsNovember 14 at 4:09 PM | reuters.comEvotec Third Quarter 2024 Earnings: Misses ExpectationsNovember 12, 2024 | finance.yahoo.comEvotec (NASDAQ:EVO) Shares Gap Up - Here's WhyEvotec (NASDAQ:EVO) Shares Gap Up - What's Next?November 11, 2024 | marketbeat.comEQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionNovember 11, 2024 | markets.businessinsider.comHC Wainwright Has Negative Outlook of Evotec FY2024 EarningsNovember 11, 2024 | americanbankingnews.comWhat is HC Wainwright's Forecast for Evotec FY2024 Earnings?Evotec SE (NASDAQ:EVO - Free Report) - Stock analysts at HC Wainwright cut their FY2024 earnings per share estimates for shares of Evotec in a research report issued to clients and investors on Thursday, November 7th. HC Wainwright analyst D. Tsao now expects that the company will post earnings oNovember 11, 2024 | marketbeat.comEarnings Release: Here's Why Analysts Cut Their Evotec SE (ETR:EVT) Price Target To €10.65November 10, 2024 | finance.yahoo.comWhat is HC Wainwright's Estimate for Evotec Q1 Earnings?Evotec SE (NASDAQ:EVO - Free Report) - Investment analysts at HC Wainwright issued their Q1 2025 earnings estimates for Evotec in a research report issued on Thursday, November 7th. HC Wainwright analyst D. Tsao expects that the company will earn ($0.01) per share for the quarter. HC Wainwright cNovember 8, 2024 | marketbeat.comDeutsche Bank Sticks to Their Sell Rating for Evotec (0IRF)November 8, 2024 | markets.businessinsider.comEvotec AG: Buy Rating Affirmed Amid Promising Growth Prospects and Strategic InitiativesNovember 8, 2024 | markets.businessinsider.comEvotec (NASDAQ:EVO) Earns Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and set a $8.00 price target on shares of Evotec in a report on Thursday.November 7, 2024 | marketbeat.comEvotec SE (EVOTF) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ...November 7, 2024 | finance.yahoo.comEvotec SE (EVO) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | seekingalpha.comJefferies Sticks to Their Hold Rating for Evotec (0IRF)November 6, 2024 | markets.businessinsider.comEvotec AG Strengthens Alliances Amidst Revenue ChallengesNovember 6, 2024 | markets.businessinsider.comEvotec SE 2024 Q3 - Results - Earnings Call PresentationNovember 6, 2024 | seekingalpha.comInsights into Evotec's Upcoming EarningsNovember 5, 2024 | benzinga.comEvotec SE (EVO) Q3 2024 Earnings Report Preview: What To ExpectNovember 5, 2024 | finance.yahoo.comEvotec To Sell Chemical API Manufacturing Site, Evotec DS, To Monacum; Terms UndisclosedNovember 5, 2024 | markets.businessinsider.comEvotec (NASDAQ:EVO) Shares Gap Up - What's Next?Evotec (NASDAQ:EVO) Shares Gap Up - Should You Buy?November 4, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - What's Next?Evotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - Here's What HappenedNovember 1, 2024 | marketbeat.comEvotec (EVO) Set to Announce Quarterly Earnings on WednesdayEvotec (NASDAQ:EVO) will be releasing earnings before the market opens on Wednesday, November 6, Zacks reports.October 31, 2024 | marketbeat.comGermany shares lower at close of trade; DAX down 0.25%October 29, 2024 | msn.comGermany stocks lower at close of trade; DAX down 0.25%October 29, 2024 | msn.comEvotec (NASDAQ:EVO) Trading Up 9.1% - What's Next?Evotec (NASDAQ:EVO) Trading 9.1% Higher - Should You Buy?October 28, 2024 | marketbeat.comDewpoint Therapeutics Announces Nomination of First C-Mod Development Candidate DPTX3186 for Treatment of Wnt-Driven CancersOctober 28, 2024 | markets.businessinsider.comWhy Is Evotec Stock Gaining Today?October 23, 2024 | benzinga.comEvotec (NASDAQ:EVO) Sees Large Volume Increase - Here's WhyEvotec (NASDAQ:EVO) Sees Strong Trading Volume - Still a Buy?October 21, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Shares Gap Up - Should You Buy?Evotec (NASDAQ:EVO) Shares Gap Up - Time to Buy?October 17, 2024 | marketbeat.comEvotec (0IRF) Receives a Buy from Warburg ResearchOctober 16, 2024 | markets.businessinsider.comEvotec (NASDAQ:EVO) Shares Gap Down - Should You Sell?Evotec (NASDAQ:EVO) Shares Gap Down - What's Next?October 14, 2024 | marketbeat.comEvotec (NASDAQ:EVO) Downgraded by Jefferies Financial GroupJefferies Financial Group lowered Evotec from a "buy" rating to a "hold" rating in a report on Monday.October 7, 2024 | marketbeat.comEvotec’s Strategic Challenges and Uncertain Outlook Lead to Hold RatingOctober 7, 2024 | markets.businessinsider.comEvotec (NASDAQ:EVO) Shares Gap Down to $3.51Evotec (NASDAQ:EVO) Shares Gap Down to $3.51October 2, 2024 | marketbeat.comNovo Holdings A S Purchases New Shares in Evotec SE (NASDAQ:EVO)Novo Holdings A S acquired a new position in shares of Evotec SE (NASDAQ:EVO - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 14,829,842 shares of the company's stock, valued at approximately $71,183,000. Evotec comprises about 3.6September 30, 2024 | marketbeat.comNovo Nordisk And Evotec Collaborate On Stem Cell-Based Therapy DevelopmentSeptember 26, 2024 | benzinga.comFocus on Powell, weekly US jobless claims and final reading of Q2 GDPSeptember 26, 2024 | fxstreet.comEvotec shares surge after technology partnership with Novo NordiskSeptember 26, 2024 | za.investing.comDAX Rallies As China Steps Up Economic SupportSeptember 26, 2024 | markets.businessinsider.comEvotec and Novo Nordisk in technology development partnershipSeptember 26, 2024 | msn.comEvotec and Novo Nordisk forge technology development partnershipSeptember 26, 2024 | reuters.comLaunch of Aptadir Therapeutics With a Novel Class of RNA InhibitorsSeptember 24, 2024 | finance.yahoo.com Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soon Click here to watch it now. EVO Media Mentions By Week EVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVO News Sentiment▼0.280.56▲Average Medical News Sentiment EVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVO Articles This Week▼203▲EVO Articles Average Week Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Arcellx News ADMA Biologics News Krystal Biotech News Avidity Biosciences News BridgeBio Pharma News Biohaven News Crinetics Pharmaceuticals News Ultragenyx Pharmaceutical News Immunovant News TG Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVO) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Evotec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
